June 20, 2024

MRKR Stock
Companies

Market Analysts see Biolase Inc [BIOL] gaining to $2. Time to buy?

Biolase Inc [NASDAQ: BIOL] closed the trading session at $0.13. The stocks have a year to date performance of -88.50 percent and weekly performance of -17.31 percent. The stock has been moved at -88.68 percent over the last six months. The stock has performed -18.87

Industry

Itron Inc. [ITRI] gain 36.22% so far this year. What now?

Itron Inc. [NASDAQ: ITRI] price plunged by -0.07 percent to reach at -$0.07. The one-year ITRI stock forecast points to a potential upside of 8.31. The average equity rating for ITRI stock is currently 2.00, trading closer to a bullish pattern in the stock market.